Back to results
US 2024/0366536 A1Published application
Modulators of a potassium channel and of trpv1 channel and uses thereof
AssigneeBsense Bio Therapeutics Ltd.
InventorsAdi RAVEH, Alon SILBERMAN, Haim BELINSON, Alan Daniel BROWN
Life of this patent
Estimating the term…
Abstract
Compounds represented by Formula I: wherein A, B, W, V, Z, Ra, Rb, n and m are as defined in the instant specification, or by Formula Ia, Ib, III, IV or V, as defined in the instant specification, and uses thereof in modulating an activity of a voltage-dependent potassium channel and/or a TRPV1 channel and in treating a medical condition associated with an activity of these channels, such as medical conditions associated with neuronal hyper-excitability, are provided.
Claims22
A compound represented by Formula III:
- Formula III
- wherein:
- D is N or C—Rb3;
- V is —(CR2R3)k-U;
- k is 0, 1 or 2;
- R2 and R3 are each independently hydrogen, alkyl, cycloalkyl and aryl;
- U is amide (—C(═O)—NR10—) or an isostere thereof;
- Z is represented by Formula II:
- wherein:
- u and q are each independently an integer of from 0 to 4, provided that u+q is at least 2;
- X is selected from —O— and —NR9—, or is absent;
- Y is selected from OR11, SR11, NR12R13 and —NR12—C(═O)—R14;
- R5, R6, R7 and R8 are each independently selected from hydrogen, halo, alkyl, haloalkyl, cycloalkyl, heteroalicyclic, aryl, alkylamine, alkoxy, haloalkoxy, hydroxy, ether and aryloxy, or, alternatively, two of R5, R6, R7, R8 and R9 form together an alicyclic or heteroalicyclic ring;
- R9, R10, R11, R12, R13 and R14 are each independently selected from hydrogen, alkyl, cycloalkyl, and aryl, or, alternatively, two of R5, R6, R7, R8, R9 and R11 or two of R5, R6, R7, R8, R9, R12 and R13 form together an alicyclic or heteroalicyclic ring;
- and
- Ra2-Ra5, Rb1-Rb4, Rc1 and Rc2 are each independently a substituent selected from alkyl, cycloalkyl, halo, haloalkyl, haloalkoxy, alkoxy, ether, aryl, heteroaryl, heteroalicyclic, aryloxy, hydroxy, amine, alkylamine, thiohydroxy, thioalkoxy, thioaryloxy, cyano, carboxylate, amide, carbamate, sulfonyl, and sulfonamide,
- and wherein:
- when D is C—Rb3, Rd l is hydrogen and Rc2 is selected from halo, alkyl and haloalkyl.
15 more elements
A compound represented by Formula I:
- wherein:
- A and B are each independently selected from an aryl and a heteroaryl;
- W is selected from —S—, —O—, —CR1(OH)—, —C(═O), and NRx, wherein said Rx forms a nitrogen-containing heterocyclic ring with one of the Ra substituents of ring A;
- n is an integer of from 1 to 5;
- m is an integer of from 0 to 4;
- Ra and Rb are each independently a substituent selected from alkyl, cycloalkyl, halo, haloalkyl, haloalkoxy, alkoxy, ether, aryl, heteroaryl, heteroalicyclic, aryloxy, hydroxy, amine, alkylamine, thiohydroxy, thioalkoxy, thioaryloxy, cyano, carboxylate, amide, carbamate, sulfonyl, and sulfonamide, or, alternatively, at least two of the Ra substituents form together an alicyclic or heterocyclic ring, at least one of the Ra substituents forms together with Rx, if present, said nitrogen-containing heterocyclic ring and/or at least two of the Rb substituents form together an alicyclic or heterocyclic ring, wherein when n is greater than 1, each Ra is the same or different substituent, and when m is greater than 1, each Rb is the same or different substituent;
- R1, if present, is hydrogen or alkyl;
- V is —(CR2R3)k-U;
- k is 0, 1 or 2;
- R2 and R3 are each independently hydrogen, alkyl, cycloalkyl and aryl;
- U is amide (—C(═O)—NR10—) or an isostere thereof;
- and
- Z is represented by Formula II:
- wherein:
- u and q are each independently an integer of from 0 to 4, provided that u+q is at least 2;
- X is selected from —O— and —NR9—, or is absent;
- Y is OR11;
- R5, R6, R7 and R8 are each independently selected from hydrogen, halo, alkyl, haloalkyl, cycloalkyl, heteroalicyclic, aryl, alkylamine, alkoxy, haloalkoxy, hydroxy, ether and aryloxy, or, alternatively, two of R5, R6, R7, R8 and R9 form together an alicyclic or heteroalicyclic ring;
- and
- R9, R10, R11, R12, R13 and R14 are each independently selected from hydrogen, alkyl, cycloalkyl, and aryl, or, alternatively, two of R5, R6, R7, R8, R9 and R11 or two of R5, R6, R7, R8, R9, R12 and R13 form together an alicyclic or heteroalicyclic ring,
- and wherein when W is —S—, —O—, —CR1(OH)—, or —C(═O), at least one of said Ra substituent(s) is selected from alkyl, haloalkyl, cycloalkyl and aryl and is at the ortho position with respect to said W;
- and
- when said Rx forms said nitrogen-containing heterocyclic ring with one of the Ra substituents of ring A, ring B is a heteroaryl.
20 more elements
Dependencies are inferred from the claim text.